High Prevalence of Fatigue Following SARS-CoV-2 Infection Independent of COVID-19 Severity

Priscilla Lynch

September 30, 2020

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

Research presented at the 2020 ESCMID Conference on Coronavirus Disease (ECCVID), held online September 23-25, shows that persistent fatigue occurs in more than half of patients recovered from COVID-19, regardless of the seriousness of their infection.

"Fatigue is a common symptom in those presenting with symptomatic COVID-19 infection. Whilst the presenting features of SARS-CoV-2 infection have been well-characterized, the medium- and long-term consequences of infection remain unexplored," explained study lead author Dr Liam Townsend, St James's Hospital and Trinity Translational Medicine Institute, Trinity College, Dublin, Ireland.

The study used a commonly used scale to determine fatigue in recovered patients, called the Chalder Fatigue Score (CFQ-11). They also looked at the severity of the patient's initial infection (need for admission and critical/intensive care); their pre-existing conditions, including depression; and various markers of immune activation (white cell counts, C-reactive protein, Interluekin-6, and sCD25).

The study included 128 participants (mean age 50 years; 54% female) who were recruited consecutively at a median of 10 weeks following clinical recovery from SARS-CoV-2 infection. More than half reported persistent fatigue (52.3%; 67/128) at this point.

Of the patients assessed in this study, 71/128 (55.5%) were admitted to hospital and 57/128 (44.5%) were not admitted. "Fatigue was found to occur independent of admission to hospital, affecting both groups equally," explained Townsend.

There was no association between COVID-19 severity (need for inpatient admission, supplemental oxygen, or critical care) and fatigue following COVID-19. Additionally, there was no association between routine laboratory markers of inflammation and cell turnover (white blood cell counts or ratios, lactate dehydrogenase, or C-reactive protein) or pro-inflammatory molecules (IL-6 or sCD25) and fatigue after COVID-19.

Female gender and those with a pre-existing diagnosis of depression/anxiety were over-represented in those with fatigue. Although women represented just over half of the patients in the study (54%), two thirds of those with persistent fatigue (67%) were women.

Follow the latest COVID-19 figures in your region and around the globe with our interactive COVID-19 map.

ECCVID 2020: Abstract 00024. Presented September 23-25, 2020.

This article originally appeared on Univadis.com.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.